NCT06521931 2026-03-02
A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 1 Completed
Clinical Trials
9 trialsNCT06245746 2025-03-21
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Recruiting
NCT02948283 2021-02-12
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
City of Hope Medical Center
Phase 1 Completed
NCT00358540 2017-11-13
Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
GlaxoSmithKline
Phase 1 Completed
NCT00735930 2015-04-02
Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003597 2014-07-24
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
Children's Oncology Group
Phase 1 Completed
NCT01345214 2014-04-01
A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Ono Pharmaceutical Co. Ltd
Phase 1 Terminated
NCT01163110 2013-11-15
Study to Investigate the Therapeutic Role of RNA Fragments in Platelet Production During Chemotherapy
Midwestern Regional Medical Center
Phase 1 Completed
NCT00001533 2006-07-17
Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine
National Institutes of Health Clinical Center (CC)
Phase 1 Completed